NLM Digital Collections

Search

Start Over Subjects Prescription Drugs -- economics ✖Remove constraint Subjects: Prescription Drugs -- economics Publication Year 2017 to 2019 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2017">2017</span> to <span class="to" data-blrl-end="2019">2019</span>

3. Assessing user fees under the Prescription Drug User Fee Amendments of 2017

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
Subject(s):
Fees and Charges
Investigational New Drug Application -- economics
Prescription Drugs -- economics
Biological Products -- economics
Orphan Drug Production -- economics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

4. Status of U.S. health insurance coverage and the potential of recent congressional health reform bills to expand coverage and lower consumer costs: invited testimony : U.S. House of Representatives, Committee on Rules : hearing on "Medicare for All Act of 2019"

Author(s):
Collins, Sara R., author
Publication:
New York, NY : The Commonwealth Fund, April 30, 2019
Subject(s):
Insurance Coverage -- economics
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- economics
Insurance, Health -- legislation & jurisprudence
Financing, Personal
Forecasting
Health Benefit Plans, Employee -- economics
Health Benefit Plans, Employee -- statistics & numerical data
Health Benefit Plans, Employee -- trends
Health Care Costs -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Income
Insurance Coverage -- trends
Insurance, Health -- trends
Insurance, Health, Reimbursement
Medically Uninsured -- statistics & numerical data
Prescription Drugs -- economics
Humans
United States
United States.

5. Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis

Author(s):
Anderson-Cook, Anna, author
Maeda, Jared, author
Nelson, Lyle, author
Publication:
[Washington, DC] : Congressional Budget Office, March 2019
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

6. Prices for and spending on specialty drugs in Medicare Part D and Medicaid

Publication:
[Washington, DC] : Congressional Budget Office, March 2019
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

7. Getting to the root of high prescription drug prices: drivers and potential solutions

Author(s):
Waxman, Henry, author
Corr, Bill, author
Martin, Kristi, author
Duong, Sophia, author
Publication:
[New York, N.Y.] : Commonwealth Fund, July 2017
Subject(s):
Cost Control
Drug Costs
Health Policy
Prescription Drugs -- economics
Drug Industry -- economics
Drugs, Generic -- economics
Economic Competition
Legislation, Drug
Orphan Drug Production -- economics
Humans
United States

8. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

Author(s):
Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Armstrong, Katrina A., author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
Subject(s):
Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Drug Costs
Financing, Personal -- statistics & numerical data
Medication Adherence -- statistics & numerical data
Administration, Oral
Antineoplastic Agents -- administration & dosage
Health Services Accessibility
Prescription Drugs -- economics
Socioeconomic Factors
Time Factors
Humans
United States

9. Summary of recent and proposed changes to Medicare prescription drug coverage and reimbursement

Author(s):
Cubanski, Juliette, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, February 2018
Subject(s):
Medicare Part B -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Formularies as Topic
Insurance, Health, Reimbursement -- economics
Medicare Part B -- legislation & jurisprudence
Medicare Part D -- legislation & jurisprudence
Humans
United States